ClinicalTrials.Veeva

Menu

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Galderma logo

Galderma

Status

Completed

Conditions

Chin Augmentation
Chin Retrusion

Treatments

Device: Restylane Lyft with Lidocaine
Device: Juvederm Voluma XC

Study type

Interventional

Funder types

Industry

Identifiers

NCT05777759
43USCH2208

Details and patient eligibility

About

The primary objective of the study is to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.

Enrollment

174 patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males or non-pregnant, non-breastfeeding females, 22 years of age or older
  • Intent to receive treatment for augmentation and correction of retrusion in the chin region.

Exclusion criteria

  • Known/previous allergy of hypersensitivity to any injectable hyaluronic acid (HA) gel or gram-positive bacterial proteins.
  • Known/previous allergy or hypersensitivity to local anesthetics, e.g., lidocaine or other amide-type anesthetics.
  • Previous or present multiple severe allergies or severe allergies, such as manifested by anaphylaxis or angioedema or family history of angioedema.
  • Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from the subnasale.
  • Any previous aesthetic procedures or implants
  • Presence of any disease or lesion near or on the area to be treated.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

174 participants in 2 patient groups

New Dermal Filler for indication: Restylane Lyft with Lidocaine
Experimental group
Description:
hyaluronic acid dermal filler
Treatment:
Device: Restylane Lyft with Lidocaine
Active Comparator: FDA approved Dermal Filler: Juvederm Voluma XC
Active Comparator group
Description:
hyaluronic acid dermal filler
Treatment:
Device: Juvederm Voluma XC

Trial contacts and locations

12

Loading...

Central trial contact

Study Director Galderma R&D; Clinical Project Manager

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems